Catherine A. Shu

Statistics

Publications

Citations

3.9K

H-Index

Active since

2012

Affiliations

Columbia University Irving Medical Center(Current)

Columbia University

Memorial Sloan Kettering Cancer Center

Yonsei University

The University of Texas MD Anderson Cancer Center

Catherine A. Shu is an author at Columbia University Irving Medical Center specializing in oncology, medicine, and non-small cell lung cancer therapy.

ORCID

Publications per year

2012–2025

Publications

Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial

Catherine A. Shu, Justin F. Gainor, Mark M. Awad et al. · The Lancet Oncology · 2020 · 640 citations

Medicine, Oncology, Pharmacology +14

Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study

Keunchil Park, Eric B. Haura, Natasha B. Leighl et al. · Journal of Clinical Oncology · 2021 · 632 citations · Full text

Medicine, Oncology, Pharmacology +17

PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers

Joshua K. Sabari, Giulia C. Leonardi, Catherine A. Shu et al. · Annals of Oncology · 2018 · 318 citations · Full text

Medicine, Cancer Biology, Oncology +17

Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With <i>BRCA</i> Mutations

Catherine A. Shu, Malcolm C. Pike, Anjali R. Jotwani et al. · JAMA Oncology · 2016 · 233 citations · Full text

Medicine, Gynecology, Surgery +10

PD‐L1 expression in non‐small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens

Jonas J. Heymann, William A. Bulman, David Swinarski et al. · Cancer Cytopathology · 2017 · 206 citations · Full text

Medicine, Oncology, Pathology +17

1–5 of 49